ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RNAZ TransCode Therapeutics Inc

1.1598
-0.0202 (-1.71%)
15 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -4.71M-4.95M-5.53M-4.9M-5.13M-5.33M-4.06M-3.29M
Pre Tax Income -4.67M-4.29M-5.13M-4.82M-4.34M-5.3M-4.09M-3.33M
Net Income -4.67M-4.29M-5.13M-4.82M-4.34M-5.3M-4.09M-3.33M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -4.67M-4.3M-5.14M-4.82M-4.34M-5.3M-4.03M-3.26M
EBITDA -4.69M-4.93M-5.5M-4.87M-5.1M-5.3M-4.03M-3.26M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -457k-726k-6.15M-18.67M-19.42M
Pre Tax Income -607k-2.34M-6.84M-17.57M-18.55M
Net Income -607k-2.34M-6.84M-17.57M-18.55M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.079-0.307-0.53-1.354-0.923
EBIT -457k-726k-5.88M-17.59M-18.5M
EBITDA -457k-726k-6.11M-18.57M-19.3M

Your Recent History

Delayed Upgrade Clock